Rosas
ActiveSummary
Rosas has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €612,739 and a net result of €14,258. Equity is growing by ~15.2% per year across the filed fiscal years. Its solvency ranks better than 77% of 16,815 sector peers (NACE 68, fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-01
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
Financial
Weakest financial yearnet €14,258 ▼71.9%
Net result drops to €14,258, the lowest in the series.
31-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
29-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
Financial
Equity above €500,000Eq €547,825 ▲12.1%
5 profitable years in a row build equity to €547,825.
14-02
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 14 days late
2022
11-02
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 11 days late
2021
30-06
Financial
Highest result since 2019net €153,419 ▲41.5%
Operating result €208,533, net result €153,419, both a record.
30-06
Financial
Liquidity triplescurrent ratio 2.43
Current ratio from 0.84 to 2.43.
29-01
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
30-06
Financial
Equity above €200,000Eq €240,402 ▲35.8%
2 profitable years in a row build equity to €240,402.
31-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Show earlier events
2019
30-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
29-01
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
31-01
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.